




Instance: composition-en-12c8a969675c3f7a6a3764899fb6a5f5
InstanceOf: CompositionUvEpi
Title: "Composition for rotarix Package Leaflet"
Description:  "Composition for rotarix Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/05/330/001"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp12c8a969675c3f7a6a3764899fb6a5f5)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - rotarix"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Rotarix is and what it is used for </li>
<li>What you need to know before your child receives Rotarix </li>
<li>How Rotarix is given </li>
<li>Possible side effects </li>
<li>How to store Rotarix </li>
<li>Contents of the pack and other information </li>
</ol> </div>"""   
          

* section[=].section[+]
  * title =  "1. What rotarix is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What rotarix is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Rotarix is a viral vaccine, containing live, attenuated human rotavirus, that helps to protect your child, 
from the age of 6 weeks, against gastro-enteritis (diarrhoea and vomiting) caused by rotavirus 
infection. </p>
<p>How Rotarix works </p>
<p>Rotavirus infection is the most common cause of severe diarrhoea in infants and young children. 
Rotavirus is easily spread from hand-to-mouth due to contact with stools from an infected person. 
Most children with rotavirus diarrhoea recover on their own. However, some children become very ill 
with severe vomiting, diarrhoea and life-threatening loss of fluids that requires hospitalisation. </p>
<p>When a person is given the vaccine, the immune system (the body s natural defences) will make 
antibodies against the most commonly occurring types of rotavirus. These antibodies protect against 
disease caused by these types of rotavirus. </p>
<p>As with all vaccines, Rotarix may not completely protect all people who are vaccinated against the 
rotavirus infections it is intended to prevent. </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take rotarix"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take rotarix"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Rotarix should not be given 
* if your child has previously had any allergic reaction to rotavirus vaccines or any of the other 
ingredients of this vaccine (listed in section 6). Signs of an allergic reaction may include itchy 
skin rash, shortness of breath and swelling of the face or tongue. 
* if your child has previously had intussusception (a bowel obstruction in which one segment of 
bowel becomes enfolded within another segment). 
* if your child was born with a malformation of the gut that could lead to intussusception. 
* if your child has a rare inherited illness which affects their immune system called Severe 
Combined Immunodeficiency (SCID). 
* if your child has a severe infection with a high temperature. It might be necessary to postpone 
the vaccination until recovery. A minor infection such as a cold should not be a problem, but 
talk to your doctor first. 
* if your child has diarrhoea or is vomiting. It might be necessary to postpone the vaccination 
until recovery. </p>
<p>Warnings and precautions 
Talk to your doctor/health care professional before your child receives Rotarix if: 
* he/she has a close contact such as a household member who has a weakened immune system, 
e.g., a person with cancer or who is taking medicines that may weaken the immune system. 
* he/she has any disorder of the gastrointestinal system. 
* he/she has not been gaining weight and growing as expected. 
* he/she has any disease or is taking any medicine which reduces his/her resistance to infection or 
if his/her mother has taken during pregnancy any medicine that may weaken the immune 
system. </p>
<p>After your child has received Rotarix, contact a doctor/health care professional right away if your 
child experiences severe stomach pain, persistent vomiting, blood in stools, a swollen belly and/or 
high fever (see also section 4  Possible side effects ). </p>
<p>As always, please take care to wash your hands thoroughly after changing soiled nappies. </p>
<p>Other medicines and Rotarix 
Tell your doctor if your child is taking, has recently taken or might take any other medicines or has 
recently received any other vaccine. </p>
<p>Rotarix may be given at the same time your child receives other normally recommended vaccines, 
such as diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b, oral or 
inactivated polio, hepatitis B vaccines as well as pneumococcal and meningococcal serogroup C 
conjugate vaccines. </p>
<p>Rotarix with food and drink 
There are no restrictions on your child s consumption of food or liquids, either before or after 
vaccination. </p>
<p>Breast-feeding 
Based on evidence generated in clinical trials, breast-feeding does not reduce the protection against 
rotavirus gastro-enteritis afforded by Rotarix. Therefore, breast-feeding may be continued during the 
vaccination schedule. </p>
<p>Rotarix contains sorbitol, sucrose, glucose, phenylalanine and sodium 
This vaccine contains 13.5 mg sorbitol in each dose.  </p>
<p>If you have been told by your doctor that the child being vaccinated has an intolerance to some sugars, 
contact your doctor before your child receives this vaccine. </p>
<p>This vaccine contains 0.15 microgram phenylalanine in each dose. Phenylalanine may be harmful if 
your child has phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up 
because the body cannot remove it properly. 
This vaccine contains less than 1 mmol sodium (23 mg) in each dose, that is to say essentially 
 sodium-free . </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take rotarix"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take rotarix"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>The doctor or nurse will administer the recommended dose of Rotarix to your child. The vaccine 
(1 mL liquid) will be given orally. Under no circumstance should this vaccine be administered by 
injection. </p>
<p>Your child will receive two doses of the vaccine. Each dose will be given on a separate occasion with 
an interval of at least 4 weeks between the two doses. The first dose may be given from the age of 6 
weeks. The two doses of the vaccine must have been given by the age of 24 weeks, although they 
should preferably have been given before 16 weeks of age.  </p>
<p>Rotarix may be given according to the same vaccination course to infants who were born prematurely, 
provided that the pregnancy had lasted at least 27 weeks. </p>
<p>In case your child spits out or regurgitates most of the vaccine dose, a single replacement dose may be 
given at the same vaccination visit. </p>
<p>When Rotarix is given to your child for the first dose, it is recommended that your child also receives 
Rotarix (and not another rotavirus vaccine) for the second dose.  </p>
<p>It is important that you follow the instructions of your doctor or nurse regarding return visits. If you 
forget to go back to your doctor at the scheduled time, ask your doctor for advice. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this vaccine can cause side effects, although not everybody gets them. </p>
<p>The following side effects may happen with this vaccine: </p>
<p>Common (These may occur with up to 1 in 10 doses of the vaccine):<br />
  diarrhoea<br />
  irritability </p>
<p>Uncommon (These may occur with up to 1 in 100 doses of the vaccine): 
  abdominal pain (see also below for signs of very rare side effects of intussusception) 
  flatulence 
  inflammation of the skin </p>
<p>Side effects that have been reported during marketed use of Rotarix include: 
  Very rare: hives (urticaria) 
  Very rare: intussusception (part of the intestine gets blocked or twisted). The signs may 
include severe stomach pain, persistent vomiting, blood in stools, a swollen belly and/or high 
fever. Contact a doctor/health care professional right away if your child experiences 
one of these symptoms. 
  blood in stools 
  in babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal 
between breaths may occur for 2-3 days after vaccination. 
  children with a rare inherited illness called Severe Combined Immunodeficiency (SCID) 
may have an inflamed stomach or gut (gastroenteritis) and pass the vaccine virus in their 
stools. The signs of gastroenteritis may include feeling sick, being sick, stomach cramps or 
diarrhoea. </p>
<p>Reporting of side effects<br />
If your child gets any of the side effects, talk to your doctor or pharmacist. This includes any possible 
side effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. How to store rotarix"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store rotarix"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this vaccine out of the sight and reach of children. </p>
<p>Do not use this vaccine after the expiry date which is stated on the carton. The expiry date refers to the 
last day of that month. 
Store in a refrigerator (2  C   8  C). 
Do not freeze. 
Store in the original package in order to protect from light. </p>
<p>After reconstitution, the vaccine contained in the oral applicator should be administered promptly. If 
the reconstituted vaccine is not used within 24 hours, it should be discarded. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines your child no longer uses. These measures will help to protect the environment. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Rotarix contains </p>
<ul>
<li>The active substances are: </li>
</ul>
<p>Human rotavirus RIX4414 strain (live, attenuated)<em><br />
not less than 106.0 CCID</em>Produced on Vero cells </p>
<ul>
<li>The other ingredients in Rotarix are:<br />
Powder: dextran, sucrose, sorbitol (E420), amino acids (including phenylalanine), Dulbecco s 
Modified Eagle Medium (DMEM) (containing phenylalanine, sodium, glucose and other 
substances), (see also section 2,  Rotarix contains sorbitol, sucrose, glucose, phenylalanine and 
sodium ) 
Solvent: calcium carbonate, xanthan gum, sterile water </li>
</ul>
<p>What Rotarix looks like and contents of the pack </p>
<p>Powder and solvent for oral suspension </p>
<p>Rotarix is supplied as a whitish powder in a single dose glass container and a separate oral applicator 
of solvent which contains a slow settling white deposit and a colourless supernatant. There is also a 
transfer adapter which allows easy transfer of the solvent into the glass container containing the 
powder for mixing the different components of the vaccine. </p>
<p>Both components must be mixed together before your child receives the vaccine. The mixed vaccine 
will appear more turbid than the solvent alone. </p>
<p>Rotarix is available in a pack of 1, 5, 10 or 25. Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer </p>
<p>GlaxoSmithKline Biologicals SA 
Rue de l Institut B-1330 Rixensart 
Belgium </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
GlaxoSmithKline Pharmaceuticals SA/NV 
T l/Tel: + 32 10 85 52 Lietuva 
GlaxoSmithKline Biologicals SA 
Tel. +370 80000<br />
GlaxoSmithKline Biologicals SA 
 . +359 80018Luxembourg/Luxemburg 
GlaxoSmithKline Pharmaceuticals SA/NV 
T l/Tel: + 32 10 85 52  esk  republika 
GlaxoSmithKline s.r.o. 
Tel: + 420 2 22 00 11 cz.info@gsk.com </p>
<p>Magyarorsz g 
GlaxoSmithKline Biologicals SA 
Tel.: +36 80088Danmark 
GlaxoSmithKline Pharma A/S 
Tlf: + 45 36 35 91 dk-info@gsk.com </p>
<p>Malta 
GlaxoSmithKline Biologicals SA 
Tel: +356 80065Deutschland 
GlaxoSmithKline GmbH &amp; Co. KG 
Tel: + 49 (0)89 360448produkt.info@gsk.com </p>
<p>Nederland 
GlaxoSmithKline BV 
Tel: + 31 (0)33 2081Eesti 
GlaxoSmithKline Biologicals SA<br />
Tel: +372 8002Norge 
GlaxoSmithKline AS 
Tlf: + 47 22 70 20 <br />
GlaxoSmithKline   A.E.B.E. 
T : + 30 210 68 82  sterreich 
GlaxoSmithKline Pharma GmbH. 
Tel: + 43 (0)1 97075 0 
at.info@gsk.com  </p>
<p>Espa a 
GlaxoSmithKline, S.A. 
Tel: + 34 900 202 es-ci@gsk.com  </p>
<p>Polska 
GSK Services Sp. z o.o. 
Tel.: + 48 (22) 576 9France 
Laboratoire GlaxoSmithKline 
T l: + 33 (0) 1 39 17 84 diam@gsk.com </p>
<p>Hrvatska 
GlaxoSmithKline Biologicals SA 
Tel.: +385 800787Portugal 
Smith Kline &amp; French Portuguesa - Produtos 
Farmac uticos, Lda. 
Tel: + 351 21 412 95 FI.PT@gsk.com </p>
<p>Rom nia 
GlaxoSmithKline Biologicals SA 
Tel: +40 800672Ireland 
GlaxoSmithKline (Ireland) Ltd 
Tel: + 353 (0)1 495 5Slovenija 
GlaxoSmithKline Biologicals SA 
Tel: +386 80688 sland 
Vistor hf. 
S mi : +354 535 7Slovensk  republika 
GlaxoSmithKline Biologicals SA 
Tel: +421 800500Italia 
Suomi/Finland 
GlaxoSmithKline S.p.A. 
Tel:+ 39 (0)45 7741 GlaxoSmithKline Oy 
Puh/Tel: + 358 10 30 30 <br />
GlaxoSmithKline Biologicals SA 
 : +357 80070Sverige 
GlaxoSmithKline AB 
Tel: + 46 (0)8 638 93 info.produkt@gsk.com 
Latvija 
GlaxoSmithKline Biologicals SA 
Tel: +371 80205United Kingdom (Northern Ireland) 
GlaxoSmithKline Biologicals SA<br />
Tel: + 44 (0)800 221 customercontactuk@gsk.com </p>
<p>This leaflet was last revised in. </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p> </div>"""      



Instance: composition-da-12c8a969675c3f7a6a3764899fb6a5f5
InstanceOf: CompositionUvEpi
Title: "Composition for rotarix Package Leaflet"
Description:  "Composition for rotarix Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/05/330/001"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp12c8a969675c3f7a6a3764899fb6a5f5)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - rotarix"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. INDLÆGSSEDDEL"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. INDLÆGSSEDDEL"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Indlægsseddel: Information til brugeren"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Indlægsseddel: Information til brugeren"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   



* section[=].section[+]
  * title = "Oversigt over indlægssedlen"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Oversigt over indlægssedlen"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal du vide, før dit barn får Rotarix 
3. Sådan gives Rotarix 
4. Bivirkninger 
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p> </div>"""   
          

* section[=].section[+]
  * title =  "1. Virkning og anvendelse"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. Virkning og anvendelse"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Rotarix er en vaccine, som indeholder levende, svækket human rotavirus. Rotarix beskytter dit barn 
fra 6-ugers-alderen mod mave-tarmkatar (diarré og opkastning), forårsaget af en rotavirus-infektion. </p>
<p>Virkning </p>
<p>Infektion med rotavirus er den mest udbredte årsag til alvorlig diarré hos spædbørn og småbørn. 
Rotavirus spredes nemt fra hånd til mund ved kontakt med afføring fra en inficeret person. De fleste 
børn med rotavirus-diarré bliver selv raske. Der er imidlertid børn, som bliver meget syge med 
alvorlig opkastning, diarré og livstruende væsketab, som kræver hospitalsindlæggelse.  </p>
<p>Når dit barn får vaccinen, vil immunsystemet (kroppens naturlige forsvar) udvikle antistoffer mod de 
mest almindelige typer rotavirus. De dannede antistoffer beskytter mod sygdomme, forårsaget af disse 
typer rotavirus. </p>
<p>Som for alle andre vacciner, giver Rotarix ikke alle vaccinerede børn fuld beskyttelse imod de 
rotavirus-infektioner, som den er beregnet til at forebygge. </p> </div>"""   
          

             
* section[=].section[+]
  * title = "2. Det skal du vide, før du begynder at tage  rotarix"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. Det skal du vide, før du begynder at tage  rotarix"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dit barn må ikke få Rotarix </p>
<ul>
<li>
<p>hvis dit barn tidligere har haft en allergisk reaktion over for en rotavirus-vaccine eller et af de 
øvrige indholdsstoffer i denne vaccine (angivet i punkt 6). Kløende hududslæt, åndenød og 
hævelse i ansigtet eller af tungen kan være tegn på en allergisk reaktion. </p>
</li>
<li>
<p>hvis dit barn tidligere har haft en speciel form for tarmslyng, hvor en del af tarmen forskubbes 
ind i en anden del (invagination). </p>
</li>
<li>
<p>hvis dit barn har en medfødt misdannelse i tarmen, som kan medføre invagination. </p>
</li>
<li>
<p>hvis dit barn har en sjælden, arvelig sygdom, kaldet svær kombineret immundefekt (SCID). </p>
</li>
<li>
<p>hvis dit barn har en alvorlig infektion med høj feber. Det kan være nødvendigt at udsætte 
vaccinationen, indtil dit barn er raskt. En mindre infektion såsom forkølelse bør ikke være noget 
problem, men tal med lægen inden vaccinationen. </p>
</li>
<li>
<p>hvis dit barn har diaré eller kaster op. Det kan være nødvendigt at udsætte vaccinationen, indtil 
dit barn er raskt.   </p>
</li>
</ul>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller sygeplejersken, før dit barn får Rotarix, hvis </p>
<ul>
<li>
<p>han/hun har tæt kontakt til personer med nedsat immunforsvar, f.eks. personer i din husstand. 
Dette kan være personer, som har en kræftsygdom eller som tager lægemidler, der svækker 
immunforsvaret. </p>
</li>
<li>
<p>han/hun har gener fra maven eller tarmen. </p>
</li>
<li>
<p>han/hun ikke vokser (vægt og højde) som forventet. 
han/hun har en sygdom eller får lægemidler, som nedsætter modstandsdygtigheden over for 
infektioner, eller hvis hans/hendes mor under graviditeten har taget lægemidler, der kan svække 
immunforsvaret.  </p>
</li>
</ul>
<p>Kontakt straks lægen eller sygeplejersken, hvis dit barn får alvorlige mavesmerter, vedvarende 
opkastning, blod i afføringen, oppustet mave og/eller høj feber efter at have fået Rotarix (se også 
afsnit 4 "Bivirkninger"). </p>
<p>Vask, som altid, hænderne grundigt efter bleskift. </p>
<p>Brug af andre lægemidler sammen med Rotarix 
Fortæl det altid til lægen, hvis dit barn tager andre lægemidler, for nylig har taget andre lægemidler 
eller planlægger at tage andre lægemidler, eller hvis dit barn for nylig har fået en anden vaccine. </p>
<p>Rotarix kan gives samtidigt med, at dit barn får andre anbefalede vacciner, så som vacciner mod 
difteri, stivkrampe, kighoste, Haemophilus influenzae type b, polio (oral eller inaktiveret), hepatitis B, 
samt konjugerede vacciner mod pneumokokker og meningokokker serotype C. </p>
<p>Brug af Rotarix sammen med mad og drikke 
Der er ingen begrænsninger for, hvad dit barn må få af mad eller drikke hverken før eller efter 
vaccination. </p>
<p>Amning 
Baseret på viden fra kliniske studier nedsætter amning ikke den beskyttelse mod rotavirus-infektion, 
som Rotarix giver. Amningen kan fortsættes under vaccinationsprogrammet. </p>
<p>Rotarix indeholder saccharose, glucose, phenylalanin og natrium 
Hvis din læge har fortalt, at dit barn ikke kan tåle visse sukkerarter, skal du kontakte din læge, inden 
dit barn bliver vaccineret. </p>
<p>Denne vaccine indeholder 0,15 mikrogram phenylalanin i hver dosis. Phenylalanin kan være skadeligt, 
hvis dit barn har phenylketonuri (PKU, Føllings sygdom), en sjælden genetisk lidelse, hvor 
phenylalanin ophobes, fordi kroppen ikke kan fjerne det ordentligt. </p>
<p>Denne vaccine indeholder 32 mg natrium (hoved komponent af madlavnings-/bordsalt) pr. dosis. </p> </div>"""   
                    
* section[=].section[+]
  * title =  "3. Sådan skal du tage rotarix"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Sådan skal du tage rotarix"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Lægen eller sygeplejersken vil give dit barn den anbefalede dosis Rotarix. Vaccinen (1,5 ml væske) 
gives i munden. Vaccinen må under ingen omstændigheder injiceres. </p>
<p>Dit barn skal have to doser af vaccinen, som vil blive givet ved hvert sit besøg med et interval på mindst 
4 uger. Første dosis kan gives fra 6-ugers-alderen. Begge doser skal være givet i 24-ugers-alderen, dog 
helst inden 16-ugers-alderen.  </p>
<p>Rotarix kan gives med samme vaccinationsinterval til børn, som er født for tidligt, under forudsætning 
af, at graviditeten har varet i mindst 27 uger.   </p>
<p>Hvis dit barn spytter det meste af den indgivne vaccinedosis ud eller gylper den op, kan en 
erstatningsdosis gives med det samme, inden du forlader lægens konsultation. </p>
<p>Hvis dit barn får Rotarix som første dosis, anbefales det, at dit barn også får Rotarix som anden dosis 
(og ikke en anden slags rotavirus-vaccine). </p>
<p>Det er vigtigt at følge din læges eller sygeplejerskens instruktioner med hensyn til efterfølgende besøg. 
Hvis du glemmer et besøg, skal du kontakte din læge. </p> </div>"""         

        
* section[=].section[+]
  * title = "4. Bivirkninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Bivirkninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Denne vaccine kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Følgende bivirkninger kan forekomme med denne vaccine: </p>
<p>♦ 
Almindelig (kan forekomme ved op til 1 ud af 10 vaccinedoser):<br />
• diarré 
• irritabilitet. </p>
<p>♦ 
Ikke almindelig (kan forekomme ved op til 1 ud af 100 vaccinedoser): 
• mavesmerter (se også nedenfor angående symptomer på invagination, som er en meget 
sjælden bivirkning) 
• luft fra tarmen 
• betændelse i huden. </p>
<p>Bivirkninger, som er set efter markedsføring af Rotarix omfatter: 
• meget sjælden: nældefeber (urticaria) 
• meget sjælden: speciel form for tarmslyng, hvor en del af tarmen forskubbes ind i en anden 
del (invagination). Symptomerne kan være alvorlige mavesmerter, vedvarende opkastning, 
blod i afføringen, opsvulmet mave og/eller høj feber. Kontakt straks lægen eller 
sygeplejersken, hvis dit barn oplever nogen af disse symptomer. 
• blod i afføringen 
• længere mellemrum mellem vejrtrækningerne hos meget for tidligt fødte børn (født i 28. svangerskabsuge eller tidligere) kan forekomme 2-3 dage efter vaccination. 
• børn, som lider af en sjælden, arvelig sygdom, kaldet svær kombineret immundefekt (SCID), 
kan have mave-tarmkatar og udskille vaccinevirus med afføringen. Kvalme, opkastning, 
mavekramper eller diaré kan være tegn på mave-tarmkatar. </p>
<p>Indberetning af bivirkninger 
Hvis dit barn får bivirkninger, bør du tale med din læge eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p> </div>"""      
        
* section[=].section[+]
  * title = "5. Opbevaring"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Opbevaring"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar vaccinen utilgængeligt for børn. </p>
<p>Brug ikke vaccinen efter den udløbsdato, der står på æsken efter EXP. Udløbsdatoen er den sidste dag 
i den nævnte måned. </p>
<p>Opbevares i køleskab (2 °C - 8 °C). 
Må ikke nedfryses. 
Opbevares i den originale yderpakning for at beskytte mod lys. </p>
<p>Vaccinen skal gives straks efter åbning. </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe lægemiddelrester. Af hensyn til miljøet må du 
ikke smide lægemiddelrester i afløbet, toilettet eller skraldespanden. </p> </div>"""      
        
        
* section[=].section[+]
  * title = "6. Pakningsstørrelser og yderligere oplysninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Pakningsstørrelser og yderligere oplysninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Rotarix indeholder </p>
<ul>
<li>Aktivt stof: </li>
</ul>
<p>Human rotavirus RIX4414 stamme (levende, svækket)* 
ikke mindre end 106,0 CCID </p>
<p>*fremstillet på veroceller </p>
<ul>
<li>Øvrige indholdsstoffer i Rotarix: 
Saccharose, dinatriumadipat, Dulbecco’s Modified Eagle Medium (DMEM) (indeholdende 
phenylalanin, natrium, glucose og andre substanser), sterilt vand (se også afsnit 2, "Rotarix 
indeholder saccharose, glucose, phenylalanin og natrium") </li>
</ul>
<p>Udseende og pakningsstørrelser </p>
<p>Oral suspension i en fyldt oral applikator. </p>
<p>Rotarix er en klar farveløs væske i en enkeltdosis fyldt oral applikator (1,5 ml).  </p>
<p>Rotarix findes i pakninger á 1, 5, 10 eller 25 stk. </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller </p>
<p>GlaxoSmithKline Biologicals SA 
Rue de l’Institut B-1330 Rixensart 
Belgien </p>
<p>Hvis du ønsker yderligere oplysninger om Rotarix, skal du henvende dig til den lokale repræsentant 
for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
GlaxoSmithKline Pharmaceuticals SA/NV 
Tél/Tel: + 32 10 85 52<br />
Lietuva 
GlaxoSmithKline Biologicals SA 
Tel: +370 80000 </p>
<p>България 
GlaxoSmithKline Biologicals SA 
Тел. +359 80018 </p>
<p>Luxembourg/Luxemburg 
GlaxoSmithKline Pharmaceuticals SA/NV 
Tél/Tel: + 32 10 85 52 Česká republika 
GlaxoSmithKline s.r.o. 
Tel: + 420 2 22 00 11 cz.info@gsk.com </p>
<p>Magyarország 
GlaxoSmithKline Biologicals SA 
Tel.: +36 80088 
Danmark 
GlaxoSmithKline Pharma A/S 
Tlf: + 45 36 35 91 dk-info@gsk.com </p>
<p>Malta 
GlaxoSmithKline Biologicals SA 
Tel: +356 80065 
Deutschland 
GlaxoSmithKline GmbH &amp; Co. KG 
Tel: + 49 (0)89 360448produkt.info@gsk.com </p>
<p>Nederland 
GlaxoSmithKline BV 
Tel: + 31 (0)33 2081 
Eesti 
GlaxoSmithKline Biologicals SA<br />
Tel: +372 8002 
Norge 
GlaxoSmithKline AS 
Tlf: + 47 22 70 20<br />
Ελλάδα 
GlaxoSmithKline Μονοπρόσωπη A.E.B.E. 
Tηλ: + 30 210 68 82<br />
Österreich 
GlaxoSmithKline Pharma GmbH 
Tel: + 43 (0)1 97075 0 
at.info@gsk.com  </p>
<p>España 
GlaxoSmithKline, S.A. 
Tel: + 34 900 202 es-ci@gsk.com  </p>
<p>Polska 
GSK Services Sp. z o.o. 
Tel.: + 48 (22) 576 9 
France 
Laboratoire GlaxoSmithKline 
Tél: + 33 (0) 1 39 17 84 diam@gsk.com </p>
<p>Portugal 
Smith Kline &amp; French Portuguesa - Produtos 
Farmacêuticos, Lda. 
Tel: + 351 21 412 95 FI.PT@gsk.com </p>
<p>Hrvatska 
GlaxoSmithKline Biologicals SA 
Tel.: +385 800787 
România 
GlaxoSmithKline Biologicals SA 
Tel: +40 800672 
Ireland 
GlaxoSmithKline (Ireland) Ltd 
Tel: + 353 (0)1 495 5Slovenija 
GlaxoSmithKline Biologicals SA 
Tel: +386 80688 
Ísland 
Vistor hf. 
Sími : +354 535 7 
Slovenská republika 
GlaxoSmithKline Biologicals SA 
Tel: +421 800500 </p>
<p>Italia 
GlaxoSmithKline S.p.A. 
Tel:+ 39 (0)45 7741<br />
Suomi/Finland 
GlaxoSmithKline Oy 
Puh/Tel: + 358 10 30 30  </p>
<p>Κύπρος 
GlaxoSmithKline Biologicals SA 
Τηλ: +357 80070 
Sverige 
GlaxoSmithKline AB 
Tel: + 46 (0)8 638 93 info.produkt@gsk.com </p>
<p>Latvija 
GlaxoSmithKline Biologicals SA 
Tel: +371 80205 </p>
<p>United Kingdom (Northern Ireland) 
GlaxoSmithKline Biologicals SA 
Tel: + 44 (0)800 221 customercontactuk@gsk.com 
Denne indlægsseddel blev senest ændret  </p>
<p>Andre informationskilder </p>
<p>Du kan finde yderligere oplysninger om Rotarix på Det Europæiske Lægemiddelagenturs hjemmeside<br />
http://www.ema.europa.eu. 
--------------------------------------------------------------------------------------------------------------------------- Nedestående oplysninger er kun til sundhedspersoner: </p>
<p>Vaccinen er en klar, farveløs væske, fri for synlige partikler til oral administration.  </p>
<p>Vaccinen er klar til brug (vaccinen skal ikke rekonstitueres eller fortyndes). 
Vaccinen skal administreres oralt uden opblanding med andre vacciner eller opløsninger. </p>
<p>Vaccinen skal undersøges visuelt for fremmede partikler og/eller usædvanligt udseende. Såfremt der 
observeres fremmede partikler eller usædvanligt udseende, skal vaccinen kasseres.  </p>
<p>Ikke anvendt vaccine eller affald heraf skal bortskaffes i henhold til lokale retningslinjer. </p>
<p>Instruktioner for administration af vaccinen: </p>
<p>Den tomme orale applikator og beskyttelseshætten skal bortskaffes i en beholder, godkendt til 
biologisk materiale og i henhold til lokale retningslinjer. </p>
<ol>
<li>Fjern beskyttelseshætten fra den 
orale applikator. </li>
<li>Denne vaccine er kun til oral 
administration. Barnet skal sidde i 
en tilbagelænet stilling. Hele 
applikatorens indhold gives i munden 
(mod indersiden af kinden). </li>
<li>Må ikke injiceres. 
Beskyttelses-
hætte på den 
orale applikator<br />
Indlægsseddel: Information til brugeren  </li>
</ol>
<p>Rotarix oral suspension i blød tube 
rotavirus-vaccine, levende </p>
<p>Læs denne indlægsseddel grundigt, inden dit barn får vaccinen, da den indeholder vigtige 
oplysninger. 
- Gem indlægssedlen. Du kan få brug for at læse den igen. 
- Spørg lægen eller apotekspersonalet, hvis der er mere, du vil vide. 
- Lægen har ordineret denne vaccine til dit barn. Lad derfor være med at give den til andre. 
- Kontakt lægen eller apotekspersonalet, hvis dit barn får bivirkninger, herunder bivirkninger, 
som ikke er nævnt i denne indlægsseddel. Se punkt 4. Se den nyeste indlægsseddel på www.indlaegsseddel.dk </p> </div>"""      





                    
Instance: bundlepackageleaflet-en-12c8a969675c3f7a6a3764899fb6a5f5
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for rotarix Package Leaflet for language en"
Description: "ePI document Bundle for rotarix Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-12c8a969675c3f7a6a3764899fb6a5f5"
* entry[0].resource = composition-en-12c8a969675c3f7a6a3764899fb6a5f5

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp12c8a969675c3f7a6a3764899fb6a5f5"
* entry[=].resource = mp12c8a969675c3f7a6a3764899fb6a5f5
                            
                    
Instance: bundlepackageleaflet-da-12c8a969675c3f7a6a3764899fb6a5f5
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for rotarix Package Leaflet for language da"
Description: "ePI document Bundle for rotarix Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-12c8a969675c3f7a6a3764899fb6a5f5"
* entry[0].resource = composition-da-12c8a969675c3f7a6a3764899fb6a5f5

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mp12c8a969675c3f7a6a3764899fb6a5f5"
* entry[=].resource = mp12c8a969675c3f7a6a3764899fb6a5f5
                            
                    



Instance: mp12c8a969675c3f7a6a3764899fb6a5f5
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Rotarix powder and solvent for oral suspension"
Description: "Rotarix powder and solvent for oral suspension"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/05/330/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Rotarix powder and solvent for oral suspension"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: 12c8a969675c3f7a6a3764899fb6a5f5ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "rotarix"

* status = #current
* mode = #working

* title = "List of all ePIs associated with rotarix"

* subject = Reference(mp12c8a969675c3f7a6a3764899fb6a5f5)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#rotarix "rotarix"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-12c8a969675c3f7a6a3764899fb6a5f5) // rotarix en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-12c8a969675c3f7a6a3764899fb6a5f5) // rotarix da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-12c8a969675c3f7a6a3764899fb6a5f5
InstanceOf: List

* insert 12c8a969675c3f7a6a3764899fb6a5f5ListRuleset
    